Clinical Trial Update: Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating RSS0343 tablets in patients with non-cystic fibrosis bronchiectasis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• RSS0343

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Adolescent Asthma | Phase 2 | Status: RECRUITING